コメント 0

2019年 英文

原著

1)        Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y,  Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H,Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M,  Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A, KAICA trial Investigators. Efficacy of primary treatment with immunoglobulin plus cyclosporine for prevention of coronary artery abnormalities in Kawasaki disease patients predicted to be at increased risk of IVIG non-response (KAICA study): a controlled, phase 3, randomised, open-label, blinded-endpoints, phase 3 trial. Lancet 2019 Mar 16;393(10176):1128-1137

2)        Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S. Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study. Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17.

3)     Harigai M, Ishiguro N, Inokuma S, Mimori T, Ryu J, Takei S, Takeuchi T, Tanaka Y, Takasaki Y, Yamanaka H, Yoshizawa Y, Chinen I, Nakao T, Koike T. Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance. Mod Rheumatol 2019 Sep;29(5):747-755

4)     Ibusuki A, Nishikawa T, Hiraki T, Okano T, Imai K, Kanegane H, Ohnishi H, Kato Z, Fujii K, Tanimoto A, Kawano Y, Kanekura T. Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene. J Dermatol. 2019 Nov;46(11):1019-1023.. doi: 10.1111/1346-8138.15054.

5)     Imamura M, Okamoto Y, Nishikawa T, Yoneyama T, Yamasaki Y, Kawamura J, Kawano Y.  Celecoxib as a Potential Treatment for Intractable Lymphatic Malformation.  Pediatrics. 2019 Sep;144(3). pii: e20190319

6)     Imashioya T, Kodama Y, Ooka T, Nakagawa S, Nishikawa T, Tanabe T, Okamoto Y, Imuta N, Kirishima M, Tanimoto A, Koriyama T, Nishi J, Kawano Y. Liver abscess due to Sterigmatomyces halophilus in a boy with acute lymphoblastic leukemia. J Infect Chemother. 2019 Dec;25(12):1047-1049

7)     Kusubae R, Nomura YHirabayashi M, Sameshima K. β2 microglobulin and lactate dehydrogenase are indices of different features of Mycoplasma pneumoniae-associated community-acquired lower respiratory tract infection for severity evaluation in children. J Infect Chemother. 2019 Dec;25(12):1007-1011

8)        Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, Momohara S, Takei S, Tamura N, Takasaki Y, Yamamoto K, Ikeuchi S, Kushimoto S, Koike T. Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study. Mod Rheumatol. 2019 Mar;29(2):314-323. doi: 10.1080/14397595.2018.1460230. PMID:29611761

9)        Nagatome Y, Ueno K, Takahashi Y, Hazeki D, Kawano Y. Neonatal ventricular tachycardia: Adverse event possibly due to maternal ritodrine. Pediatr Int. 2019 Mar;61(3):298-299

10)     Nakagawa S, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y.Importance of Acute Lymphoblastic Leukemia-type Therapy for Bilineal Acute Leukemia. J Pediatr Hematol Oncol.  2019 Aug;41(6):504-506.

11)     Nishikawa T, Yamaguchi H, Ikawa K, Nakayama K, Higashi E, Miyahara E, Abematsu T, Nakagawa S, Kodama Y, Tanabe T, Shigemi A, Shinkoda Y, Okamoto Y, Takeda Y, Kawano Y. Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children. Pediatrics International 2019 Jun; 61(6): 558-565. doi: 10.1111

12)     Nomura Y, Seki S, Hazeki D, Ueno K, Tanaka Y, Masuda K, Nishibatake M, Yoshinaga M. Risk factors for development of ventricular tachycardia in patients with ventricular premature contraction with a structurally normal heart. J Arrhythmia. 2019;00:1–7

13)     Ohmori H, Kada A, Nakamura M, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Mizukami A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Sano N, Tanuma N, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T. Deep Vein Thrombosis in Severe pIIotor and lntellectual Disabilities Patients and lts Treatlnent by Anticoagulants of Warfarin Versus Edoxaban. Annals of Vascular Diseases 2019 Sep; 12(3):372-378

14)     Osone S, Fukushima K, Yano M, Kakazu M, Sano H, Kato Y, Shinkoda Y, Shinoda K, Mori N, Adachi S. Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan. Int J Hematol. 2019 Dec;110(6):743-750.

15)      Saito A, Nishikawa T, Oyoshi T, Nakagawa S, Kodama Y, Yamada A, Kinoshita M, Okamoto Y, Arita K, Moritake H, Kawano Y. Giant radiation-induced cavernous haemangioma before reduced-intensity bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant. 2019 Feb;54(2):312-315. doi:10.1038/s41409-018-0272-8.

16)     Seki Y, Okamoto Y, Kodama Y, Nishikawa T, Kawano Y. Slowly progressive acute lymphoblastic leukemia after stem cell transplantation. Pediatr Int. 2019 Aug;61(8):831-832

17)        Sonoda K, Matsunari Y, Takei S. A low-birth-weight risk assessment scale:development and validation through a questionnaire-based survey. BMC Health Serv Res (Online J) 2019 Jan 18;19(1):48.

18)        Ueno K, Seki S, Shiokawa N, Matsuba T, Miyazono A, Hazeki D, Imoto Y, Kawano Y. Validation of acute kidney injury according to the modified KDIGO criteria in infants after cardiac surgery for congenital heart disease. Nephrology. 2019 Mar;24(3):294-300. doi: 10.1111/nep.13240. PMID:29451341

19)     Yamasaki Y, Takei S, Imanaka H, Kubota T, Nonaka Y, Takezaki T, Kawano Y. S100A12 and vascular endothelial growth factor can differentiate Blausyndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis. Clin Rheumatol. 2019 Mar;38(3):835-840.  doi:10.1007/s10067-018-4359-9  PMID:30406853

20)        Yatsushiro Y, Nishikawa T, Saito A, Nakazawa Y, Imadome KI, Nakagawa S, Kodama Y, Okamoto Y, Kanegane H, Kawano Y. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol. 2019 Jan;41(1):e44-e46.

コメントを残す

以下に詳細を記入するか、アイコンをクリックしてログインしてください。

WordPress.com ロゴ

WordPress.com アカウントを使ってコメントしています。 ログアウト /  変更 )

Google フォト

Google アカウントを使ってコメントしています。 ログアウト /  変更 )

Twitter 画像

Twitter アカウントを使ってコメントしています。 ログアウト /  変更 )

Facebook の写真

Facebook アカウントを使ってコメントしています。 ログアウト /  変更 )

%s と連携中